Objective: The purpose of this 8-week, randomised, single-blind, parallel group, multicentre,
comparative study was to evaluate the efficacy, safety and tolerability of the dihydropyridine …

Abstract The Syst-Eur trial investigated whether active treatment starting with the
dihydropyridine calcium channel blocker (CCB) nitrendipine, could reduce the …

Background Around 40% of the elderly population suffer from arterial hypertension. An
effective antihypertensive treatment is therefore required. Calcium antagonists are used to …

More than 50% of hypertensive patients are aged above 65 years. Physiopathology of
essential hypertension is different in the elderly as compared with the young adult …

Systolic hypertension is a major health economy problem within our aging society.
Increased arterial stiffness is the vascular phenotype of systolic hypertension, especially of …

Cardiovascular diseases are the most common causes of mortality, and hypertension is the
most common cardiovascular disease in all ages. The Systolic Hypertension in the Elderly …

OBJECTIVE: To review the prevalence, pathophysiology, vascular risk, and treatment of
isolated systolic hypertension (ISH) in the elderly. DATA SOURCE: A MEDLINE search of …

Isolated systolic hypertension affects 8% to 15% of all people older than 60 years of age. In
the elderly, systolic hypertension is the major modifiable cardiovascular risk factor. Three …

To investigate the efficacy and tolerability of lercanidipine, used as monotherapy once a day,
in elderly patients with isolated systolic hypertension (ISH), 83 patients were enrolled in this …

The Syst-Eur study investigated whether active antihypertensive treatment could reduce
cardiovascular complications in elderly patients with isolated systolic hypertension …